Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 18, 2015 07:00 ET | Source: Melinta Therapeutics, Inc.

FDA Grants Qualified Infectious Disease Product Designation to Taksta(TM) Cempra's Fusidic Acid Antibiotic

CHAPEL HILL, N.C., Sept. 18, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
September 10, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present Data From Antibiotic Drug Development Programs at ICAAC/ICC 2015 Meeting

CHAPEL HILL, N.C., Sept. 10, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
September 03, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present at Three Upcoming Investor Conferences

CHAPEL HILL, N.C., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
August 19, 2015 07:00 ET | Source: Melinta Therapeutics, Inc.

FDA Grants Fast Track Designation to Cempra for Solithromycin in the Treatment of Community Acquired Bacterial Pneumonia

CHAPEL HILL, N.C., Aug. 19, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
August 04, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present at the Wedbush PacGrow 2015 Healthcare Conference

CHAPEL HILL, N.C., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
July 29, 2015 16:04 ET | Source: Melinta Therapeutics, Inc.

Cempra Reports Second Quarter 2015 Financial Results and Provides Corporate Update

CHAPEL HILL, N.C., July 29, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
July 22, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Report Second Quarter 2015 Financial Results

CHAPEL HILL, N.C., July 22, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
July 07, 2015 07:00 ET | Source: Melinta Therapeutics, Inc.

Cempra Completes Patient Enrollment of Solitaire-IV Phase 3 Clinical Trial

CHAPEL HILL, N.C., July 7, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
May 26, 2015 07:30 ET | Source: Melinta Therapeutics, Inc.

Cempra to Present at the Jefferies 2015 Global Healthcare Conference

CHAPEL HILL, N.C., May 26, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...
May 19, 2015 07:00 ET | Source: Melinta Therapeutics, Inc.

Cempra Presenting Additional Data From the Phase 3 Oral Solithromycin Study in Community Acquired Bacterial Pneumonia at the American Thoracic Society Conference

CHAPEL HILL, N.C., May 19, 2015 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right